Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-22-013821
Filing Date
2022-08-19
Accepted
2022-08-19 17:17:44
Documents
67
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q rsls-20220630x10q.htm   iXBRL 10-Q 1941742
2 EX-31.1 rsls-20220630xex31d1.htm EX-31.1 11731
3 EX-31.2 rsls-20220630xex31d2.htm EX-31.2 11979
4 EX-32.1 rsls-20220630xex32d1.htm EX-32.1 9399
5 EX-32.2 rsls-20220630xex32d2.htm EX-32.2 9212
  Complete submission text file 0001558370-22-013821.txt   7702388

Data Files

Seq Description Document Type Size
6 EX-101.SCH rsls-20220630.xsd EX-101.SCH 41902
7 EX-101.CAL rsls-20220630_cal.xml EX-101.CAL 57558
8 EX-101.DEF rsls-20220630_def.xml EX-101.DEF 228775
9 EX-101.LAB rsls-20220630_lab.xml EX-101.LAB 395393
10 EX-101.PRE rsls-20220630_pre.xml EX-101.PRE 346061
61 EXTRACTED XBRL INSTANCE DOCUMENT rsls-20220630x10q_htm.xml XML 1418543
Mailing Address 1001 CALLE AMANECER SAN CLEMENTE CA 92673
Business Address 1001 CALLE AMANECER SAN CLEMENTE CA 92673 949-429-6680
ReShape Lifesciences Inc. (Filer) CIK: 0001427570 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37897 | Film No.: 221181605
SIC: 3841 Surgical & Medical Instruments & Apparatus